Related Experiment Video

Updated: Aug 20, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Asymptomatic hypoglycaemia: identification and impact

Ramon Gomis1, Enric Esmatjes

  • 1Endocrinology and Diabetes Service, Hospital Clínic Universitari, IDIBAPS, Faculty of Medicine, University of Barcelona, Barcelona, Spain. gomis@medicina.ub.es

Diabetes/Metabolism Research and Reviews
|November 20, 2004
PubMed

Insights

Intensive diabetes management can cause hypoglycemia, impairing awareness. Frequent self-monitoring of blood glucose (SMBG) is recommended but is invasive and provides an incomplete picture of glucose levels.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Mellitus Research

Background:

  • Intensive diabetes management, proven effective by the Diabetes Control and Complications Trial (DCCT), delays microvascular complications in type 1 diabetes.
  • Intensive regimens are associated with increased hypoglycemia, and impaired awareness of hypoglycemia symptoms is reported in up to 50% of type 1 diabetes patients.
  • Self-monitoring of blood glucose (SMBG) is crucial for diabetes management, but current methods have limitations.

Purpose of the Study:

  • To address the limitations of intermittent finger-stick blood glucose monitoring.
  • To explore alternative methods for assessing glycemic control in type 1 diabetes.
  • To improve patient acceptance and adherence to monitoring protocols.

Main Methods:

  • Review of existing literature on diabetes management and monitoring techniques.
  • Analysis of the challenges associated with frequent self-monitoring of blood glucose (SMBG).
  • Discussion of the impact of impaired hypoglycemic awareness on diabetes control.

Main Results:

  • Intensive diabetes management effectively reduces microvascular complications.
  • Hypoglycemia and impaired awareness of its symptoms are significant challenges in intensive diabetes therapy.
  • Current SMBG methods are invasive, painful, and provide an incomplete glycemic profile.

Conclusions:

  • There is a need for improved methods for monitoring blood glucose levels in type 1 diabetes.
  • Enhanced monitoring strategies could mitigate risks associated with intensive management and improve patient outcomes.
  • Addressing the limitations of SMBG is essential for better diabetes self-care and reduced complication rates.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...